WHO Puts a Hold on TB Drugs from India

Tuberculosis drugs from Svizera Labs have been suspended following an investigation into quality
March 23, 2016

The World Health Organization has suspended the approval of tuberculosis drugs from India's Svizera Labs, according to a Reuters article. This decision comes following an investigation into quality standards.

The agency reportedly said it put a hold on all TB products made at Svizera's Mumbai site because manufacturing standards and quality management were unreliable. Read the full story

Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates